Teva Pharmaceutical Industries reported $7.75B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Aspen Pharmacare ZAR 81.09B 3.81B Dec/2025
Cipla INR 344.32B 15.13B Mar/2026
Dr.Reddys Laboratories INR 386.74B 7.82B Jun/2026
Guangzhou Baiy CNY 40.21B 1.68B Jun/2026
Jiangsu Hengrui CNY 64.47B 840.17M Jun/2026
Kalbe Farma IDR 25.73T 932.8B Mar/2026
Richter Gedeon HUF 1.46T 59.22B Mar/2026
Sh Fosun Pharma CNY 49.34B 196.61M Jun/2026
Sun Pharmaceuticals INR 835.7B 57.5B Mar/2026
Teva Pharmaceutical Industries USD 7.75B 475M Jun/2026